Governance QuidelOrtho Corporation

QDEL

US2197981051

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX Other stock markets 15:38:42 17/02/2026 GMT			5-day change	1st Jan Change
22.78 ^USD	-3.37%		-20.34%	-18.52%

02-16	QuidelOrtho Corporation Enters Strategic Supply Agreement to Expand Global Immunoassay Portfolio	CI
02-13	Joseph M. Busky to Retire as Principal Financial Officer of Quidelortho Corporation, Effective as of June 30, 2026	CI

Executive Committee: QuidelOrtho Corporation

Manager

Positions heldSince

Brian Blaser

61 year

Chief Executive Officer	05/05/2024
President	05/05/2024

Juliet C. Cunningham

Investor Relations Contact

Jonathan Siegrist

Chief Tech/Sci/R&D Officer

06/10/2024

Patrick Klein

Chief Administrative Officer

30/04/2022

Michelle Hodges

Compliance Officer	-
General Counsel	30/11/2020

Philip McLellan

57 year

Chief Operating Officer

14/11/2024

Joseph Busky

58 year

Comptroller/Controller/Auditor	-
Director of Finance/CFO	-

Werner Kroll

69 year

Chief Tech/Sci/R&D Officer

Lee Bowman

Human Resources Officer

09/09/2024

Composition of the Board of Directors: QuidelOrtho Corporation

Director

CommitteesSince

Kenneth Buechler

72 year

Governance Committee	10/12/2022
Nominating Committee	10/12/2022

Evelyn Dilsaver

71 year

Governance Committee	17/12/2009
Nominating Committee	17/12/2009
Audit Committee Chair	10/05/2015
Compensation Committee	12/05/2024
HR Committee	31/07/2014
Governance Committee Chair	12/05/2024
Nominating Committee Chair	12/05/2024
Audit Committee	12/05/2024

Kenneth Widder

73 year

Audit Committee	31/12/2013
Governance Committee Chair	31/12/2013
Nominating Committee Chair	31/12/2013
Governance Committee	13/06/2023
Nominating Committee	13/06/2023

Ann Rhoads

60 year

Governance Committee	29/03/2012
Nominating Committee	29/03/2012
Audit Committee Chair

Matthew Strobeck

53 year

Audit Committee	31/12/2017
Governance Committee Chair	31/12/2011
Nominating Committee Chair	31/12/2011

R. Huennekens

61 year

Audit Committee	05/01/2025
Governance Committee	17/12/2019
Nominating Committee	17/12/2019

Joseph Wilkins

64 year

Compensation Committee	31/12/2020
Governance Committee	31/12/2020
Nominating Committee	31/12/2020

Brian Blaser

61 year

Audit Committee Chair

11/12/2022

Mary Polan

82 year

Compensation Committee

31/12/1992

Edward Michael

68 year

Compensation Committee Chair

31/12/2017

John Chiminski

62 year

Director/Board Member	05/12/2024
Independent Dir/Board Member	05/12/2024

Latest Appointments: QuidelOrtho Corporation

02-13	Joseph M. Busky to Retire as Principal Financial Officer of Quidelortho Corporation, Effective as of June 30, 2026	CI
02-05	QuidelOrtho Corp Announces Departure of Director Matthew W. Strobeck	CI
19/08/25	Quidelortho welcomes Erich Wolff as EVP, strategy & corporate development	RE
19/08/25	QuidelOrtho Corporation Appoints Erich Wolff as Executive Vice President, Strategy & Corporate Development	CI
07/07/25	QuidelOrtho Corporation Announces Management Appointments	CI
07/07/25	Quidelortho strengthens leadership team with appointments of senior vice presidents for global quality and clinical & regulatory affairs	RE
10/12/24	QuidelOrtho Corporation Appoints John R. Chiminski and R. Scott Huennekens as Board of Directors	CI

More news

Former Officers and Directors: QuidelOrtho Corporation

Insider

Positions held

SinceUntil

Robert Schmidt

Director/Board Member	31/12/2021	20/11/2024
Independent Dir/Board Member	31/12/2021	20/11/2024

James Prutow

Director/Board Member	27/11/2023	20/11/2024
Independent Dir/Board Member	27/11/2023	20/11/2024

Robert Bujarski

Chief Operating Officer	31/08/2020	14/11/2024
General Counsel	30/06/2005	31/08/2020
President	20/02/2024	05/05/2024

Michael Iskra

Chief Executive Officer	20/02/2024	05/05/2024
Corporate Officer/Principal	05/05/2024	14/11/2024

Louise Brandy

Chief Tech/Sci/R&D Officer

30/04/2024

Douglas Bryant

Director/Board Member	10/12/2022	20/02/2024
Chief Executive Officer	28/02/2009	20/02/2024
Chairman	28/02/2009	10/12/2022
President	10/12/2022	20/02/2024

Stephen Wise

Director/Board Member	31/12/2021	27/11/2023
Independent Dir/Board Member	31/12/2021	27/11/2023

Chris Smith

Director/Board Member

31/12/2021

30/08/2023

Age distribution of managers

Parity Men Women

Male	16
Female	4

Of which Executive Committee

Male	7
Female	2

Of which Directors

Male	9
Female	2

Revisions

Recommandations analystes

Évolution recommandations analystes 1 an

Évolution recommandations analystes 4 mois

Objectif analystes

Évolution objectif analystes 1 an

Évolution objectif analystes 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Conforme à la finance Islamique

QuidelOrtho Corporation is engaged in vitro diagnostics, developing and manufacturing intelligent solutions. The Company sells its products directly to end users through a direct sales force and through a network of distributors, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, other point-of-care (POC) settings, blood banks and donor centers, as well as for individual, non-professional, over the counter (OTC) use. The Company provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Connect, Ortho Plus, Ortho Vision, QuickVue, Quidel, QuidelOrtho, QVue, Savanna, Sofia, Solana, Thyretain, Triage, Virena, Vitros among others. It provides support for its customers across more than 130 countries and territories.

Employees

6,600

Sector

Advanced Medical Equipment & Technology

Calendar

05-12 - Q1 2026 Earnings Release (Projected)

More about the company